Secondary progressive multiple sclerosis - clinical course and potential predictive factors

被引:0
|
作者
Pokryszko-Dragan, Anna [1 ]
Gruszka, Ewa [1 ]
Bilinska, Matgorzata [1 ]
Dubik-Jezierzanska, Marta [2 ]
机构
[1] Akadem Med We Wroctawiu, Katedra & Klin Neurol, PL-50556 Wroclaw, Poland
[2] Dolnoslaskj Szpital Specjalistczny T Marciniaka W, Oddzial Neurol Dzieciecej, Wroclaw, Poland
关键词
multiple sclerosis; secondary progressive multiple sclerosis; course of the disease; predictive factors;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: To characterize the course of secondary progressive multiple sclerosis (SPMS), with an attempt to assess the predictive value of early clinical variables. Material and methods: Medical records of 100 patients with SPMS (40 men, 60 women, aged 34-73) were analyzed retrospectively Age at onset of MS, first symptoms, annual exacerbation rate (AER), time to progressive phase (TTP), degree of disability at its beginning (Expanded Disability Status Scale; EDSS SP), and annual progression in disability in relapsing-remitting and progressive phases (APD RR and APD SP) were compared for the gender subgroups, and the relationships between them were analyzed. Results: Time to progressive phase range was 2-29 years (mean 11.51) and EDSS SP 2-7.5 (mean 5.55). Time to progressive phase in women was longer and EDSS SP was lower than in men. Age at onset of MS, AER and ADP RR correlated positively with TTP. Optic neuritis was the most common first symptom (4996; motor deficit and cerebellar/brain stem involvement 26176 and 2196, respectively). Time to progressive phase in the former subgroup was shorter than in the latter, but no differences in ADP SP were found. Annual progression in disability in relapsing-remitting was higher than APD SP Degree of disability at its beginning (EDSS SP) correlated negatively with ADP SP Conclusions: Older age at onset, male gender, frequent relapses and fast increase in disability in the relapsing-remitting phase are risk factors for conversion to SPMS. Increase in disability during the progressive phase is slower than in the relapsing-remitting phase and depends mainly on initial EDSS. Individual variability of the course of MS has to be considered.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [1] Risk factors for secondary progressive multiple sclerosis
    Gruszka, E.
    Pokryszko-Dragan, A.
    Dubik-Jezierzanska, M.
    Bilinska, M.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S161 - S161
  • [2] In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis
    Calabro, Marco
    Lui, Maria
    Mazzon, Emanuela
    D'Angiolini, Simone
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [3] Comparative clinical immunologic analysis of the remittent and secondary-progressive course of multiple sclerosis
    Gusev, EI
    Belyaeva, IA
    Chekhonin, VP
    Demina, TL
    Boyko, AN
    Buglak, AV
    Gurina, OI
    [J]. ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2000, 100 (06): : 51 - 57
  • [4] Clinical course of progressive multiple sclerosis in Brazilian patients
    Vasconcelos, C. C. F.
    Miranda-Santos, C. M.
    Alvarenga, R. M. P.
    [J]. NEUROEPIDEMIOLOGY, 2006, 26 (04) : 233 - 239
  • [5] Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course
    Miller, Elzbieta
    Walczak, Anna
    Majsterek, Ireneusz
    Kedziora, Jozef
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2013, 257 (1-2) : 97 - 101
  • [6] Clinical and laboratory features of primary progressive and secondary progressive multiple sclerosis
    Bashir, K
    Layton, B
    Whatley, W
    Whitaker, JN
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : 466 - 466
  • [7] Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis
    Hayton, T.
    Furby, J.
    Smith, K. J.
    Altmann, D. R.
    Brenner, R.
    Chataway, J.
    Hunter, K.
    Tozer, D. J.
    Miller, D. H.
    Kapoor, R.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (02) : 237 - 245
  • [8] Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis
    T. Hayton
    J. Furby
    K. J. Smith
    D. R. Altmann
    R. Brenner
    J. Chataway
    K. Hunter
    D. J. Tozer
    D. H. Miller
    R. Kapoor
    [J]. Journal of Neurology, 2012, 259 : 237 - 245
  • [9] Potential benefit of continuous immunotherapies for secondary progressive multiple sclerosis
    Odo, T.
    Araki, M.
    Lin, Y.
    Takahashi, Y.
    Yamamura, T.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 921 - 921
  • [10] Objective classification of multiple sclerosis disease course results in frequent reclassification to secondary progressive multiple sclerosis
    Hillert, Jan
    Forsberg, Lars
    Manouchehrinia, Ali
    Ramanujam, Ryan
    Spelman, Timothy
    Klyve, Pernilla
    Drahota, Jiri
    Horakova, Dana
    Joensen, Hanna
    Magyari, Melinda
    Ellenberger, David
    Stahmann, Alexander
    Van der Walt, Anneke
    Rodgers, Jeff
    Witts, James A.
    Middleton, Rod
    Nicholas, Richard
    Bezlyak, Vladimir
    Adlard, Nicholas
    Hach, Thomas
    Lines, Carol
    Glaser, Anna
    [J]. NEUROLOGY, 2021, 96 (15)